Results 11 to 20 of about 2,560 (200)

Nanomaterials for Skin Cancer Photoimmunotherapy

open access: yesBiomedicines, 2023
Skin cancer is one of the most common types of cancer, and its incidence continues to increase. It is divided into two main categories, melanoma and non-melanoma. Treatments include surgery, radiation therapy, and chemotherapy.
Carlota M. Relvas   +4 more
doaj   +4 more sources

Overcoming Resistant Cancerous Tumors Through Combined Photodynamic and Immunotherapy (Photoimmunotherapy) [PDF]

open access: yesFrontiers in Immunology
Cancer is a major health problem as it causes significant mortality globally. In the last decades, conventional and recent therapeutic approaches have been used in oncology for cancer treatment.
Heidi Abrahamse
exaly   +4 more sources

Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent And/Or Metastatic Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesHead and Neck
Background ASP-1929 photoimmunotherapy-cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation-results in rapid, selective cell killing.Methods This phase Ib/II open-label study evaluated ASP-1929 photoimmunotherapy plus ...
Katharine A Price
exaly   +3 more sources

Cerium End-Deposited Gold Nanorods-Based Photoimmunotherapy for Boosting Tumor Immunogenicity

open access: yesPharmaceutics, 2023
Background: Triple-negative breast cancer (TNBC) was closely related to high metastatic risk and mortality and has not yet found a targeted receptor for targeted therapy.
Yanlin Feng   +7 more
doaj   +2 more sources

EGFR-targeted photoimmunotherapy and its association with the immune microenvironment in locoregional recurrent head and neck squamous cell carcinoma [PDF]

open access: yesFrontiers in Immunology
BackgroundEpidermal growth factor receptor (EGFR)-targeted photoimmunotherapy using cetuximab sarotalocan sodium (RM-1929) represents a novel therapeutic modality that induces selective tumor cell death and may influence the tumor immune microenvironment
Koichi Yoshizawa   +21 more
doaj   +2 more sources

NIR-II emissive nanomedicine of dimer-structured conjugated oligomer induces immunogenic cell death for photoimmunotherapy of pancreatic cancer [PDF]

open access: yesJournal of Nanobiotechnology
Pancreatic cancer is a highly immunosuppressive “cold” tumor that typically fails to achieve satisfactory immunotherapy outcomes. Photoimmunotherapy represents a preeminent cancer treatment strategy that combines the advantages of noninvasive ...
Cui Cen   +13 more
doaj   +2 more sources

Regulating Glucose Metabolism With Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

open access: yesAdvanced Science, 2021
The low immunogenicity, insufficient infiltration of T lymphocytes, and dismal response to immune checkpoint blockade therapy pose major difficulties in immunotherapy of pancreatic cancer.
Mingyue Zheng, Haijun Yu, Feisheng Zhong
exaly   +2 more sources

CD47-Targeted Optical Molecular Imaging and Near-Infrared Photoimmunotherapy in the Detection and Treatment of Bladder Cancer

open access: yesMolecular Therapy - Oncolytics, 2022
Transurethral resection of bladder tumor (TURBT) followed by intravesical therapy remains the most effective strategy for the management of non-muscle-invasive bladder cancer worldwide.
Xiaofeng Yang, Liu Chao, Yongjun Yang
exaly   +3 more sources

Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting [PDF]

open access: yesJournal of Nanobiotechnology, 2020
Background Photoimmunotherapy involves targeted delivery of photosensitizers via an antibody conjugate (i.e., photoimmunoconjugate, PIC) followed by light activation for selective tumor killing.
Barry J. Liang   +5 more
doaj   +2 more sources

In situ photoimmunotherapy is ineffective in treating deeply invasive squamous cell carcinoma

open access: yesDermatologica Sinica, 2014
In situ photoimmunotherapy (ISPI) can be a treatment option for selected cutaneous malignancies in patients who are not surgical candidates. We herein report the case of a large, ulcerating poorly differentiated squamous cell carcinoma (SCC) affecting ...
Tak-Wah Wong   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy